CDC assesses risk to general population as low but taking precautions due to potential severity of cases and human-to-human transmission
Department of Health and Human Services signs $176 million contract with Moderna
Early stage testing results for Moderna's H5N1 vaccine should be available in coming weeks, late-stage testing won't begin until 2025
Moderna using mRNA technology similar to COVID-19 vaccines for H5N1 vaccine development
US government investing in Moderna's mRNA vaccine development for potential bird flu pandemic
US government's investment in Moderna's H5N1 vaccine part of new Rapid Response Partnership Vehicle Consortium
The US government is taking steps to prepare for a potential bird flu pandemic by investing in the development of an mRNA vaccine from Moderna. According to multiple reports, the Department of Health and Human Services (HHS) has signed a contract with Moderna worth $176 million to create a vaccine for pandemic flu, specifically targeting the H5N1 strain that is currently circulating among birds. The deal comes as concerns grow over the possibility of human-to-human transmission and the potential severity of cases.
The early stage testing results for Moderna's mRNA vaccine for pandemic flu should be available in the coming weeks, but late-stage testing won't begin until 2025. The government already has 4.8 million doses of a traditional H5 vaccine under production, which is tailored to the currently circulating strains of the H5N1 bird flu virus.
The US Centers for Disease Control and Prevention (CDC) has assessed that the risk to the general population remains low, but officials are taking precautions. The American Veterinary Medical Association has identified H5N1 bird flu in dairy cows in 12 states, and three farm workers have tested positive for the virus. Even if a vaccine were available, vaccination might not be the best approach to protect farm workers due to limited uptake and mild illnesses.
Moderna's bird flu vaccine uses mRNA technology similar to its COVID-19 vaccines. The company announced on Tuesday that it had received funding from the US government through BARDA (Biomedical Advanced Research and Development Authority) for a late-stage clinical trial of its H5N1 vaccine. This partnership is part of a new Rapid Response Partnership Vehicle (RRPV) Consortium, which aims to help the country better prepare for pandemic threats and develop medical countermeasures.
The US government's investment in Moderna's mRNA vaccine for pandemic flu underscores the importance of being prepared for potential health crises. The COVID-19 pandemic has shown that quick action and effective vaccines can save lives and mitigate the impact on society.
US government will pay Moderna $176 million for developing an mRNA vaccine against a pandemic influenza virus H5N1
Phase 3 trial for Moderna’s H5N1 vaccine is expected to begin in 2025
Dawn O’Connell, assistant secretary for Preparedness and Response, spoke about the growing concern that H5N1 outbreak could spark another pandemic
Accuracy
]US government will pay Moderna $176 million for developing an mRNA vaccine against a pandemic influenza virus H5N1[
The new contract is worth $176 million and will help the government stay ‘nimble’
Moderna is collaborating with the US government to fund a late-stage trial of its bird flu vaccine.
The agreement ensures ‘fair pricing’ for American consumers.
Deception
(30%)
The article contains selective reporting as it only reports details that support the author's position about the US government's preparation for a bird flu pandemic with Moderna. It does not mention any potential issues or criticisms regarding Moderna or the vaccine development process. Additionally, there is emotional manipulation through phrases like 'pandemic fears', 'unprecedented outbreak', and 'shocking to watch the ineptitude' of the US response.
mRNA vaccine technology offers advantages in efficacy, speed of development, and production scalability and reliability in addressing infectious disease outbreaks.
Pandemic fears
The award made today is part of our longstanding commitment to strengthen our preparedness for pandemic influenza.
The funding flows through BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (RRPV) Consortium.
Fallacies
(85%)
The author makes several appeals to authority and uses inflammatory rhetoric. She quotes experts criticizing the US response to the bird flu outbreak and describes it as 'ineptitude'. However, she does not provide any evidence of logical fallacies in their statements or her own assertions. The author also mentions that federal agencies have limited authority within states and that farmers have resisted partnering with them, but she does not provide any examples or evidence to support this claim. This lack of concrete evidence makes it difficult to determine if there are any formal logical fallacies in the article.
]The US is badly fumbling its response to the unprecedented outbreak, drawing criticism from US-based and international experts alike.[
In a presentation in London last month, global health leader Seth Berkley said it was ‘shocking to watch the ineptitude’ of the US response to the H5N1 outbreak.
But there has been little voluntary participation on both fronts.
US Department of Health and Human Services signed a contract with Moderna to develop an mRNA vaccine for pandemic flu that is not mentioned in other articles
Results from early stage testing of Moderna’s mRNA vaccine for pandemic flu should be available in coming weeks which is not mentioned in the other articles
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(95%)
No ad hominem fallacies found. No false dilemmas or dichotomous depictions found. No appeals to authority without evidence or expertise. Inflammatory rhetoric is minimal and not a central focus of the article. There are some instances of potential oversimplification, but they do not rise to the level of logical fallacies.
The US Department of Health and Human Services announced Tuesday a contract with Moderna to develop an mRNA vaccine that targets pandemic flu...
Moderna is collaborating with the US government to fund a late-stage trial of its bird flu vaccine.
Moderna's bird flu vaccine uses messenger RNA technology like its COVID-19 vaccines.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(95%)
The article contains some instances of appeals to authority and inflammatory rhetoric, but no formal or dichotomous fallacies are present. The author quotes several sources, including federal officials and the Centers for Disease Control and Prevention, to establish the facts of the situation. These quotes do not constitute fallacies as they accurately represent the positions of those quoted.
][Federal official] told Bloomberg on Tuesday that the agreement will ensure “fair pricing” for American consumers.[/]
[The current strain of bird flu, or H5N1, surged in the United States earlier this year.]
[Scientists have also voiced concern over another strain of the virus, H5N2, which led to the death of a 59-year-old man in Mexico in early June. That was the first recorded H5N2 case in humans, according to the World Health Organization.]
